1. Prostate imaging in malignant and benign conditions

   • Aaron Sulman
   • Martin I. Resnick

   Invited Commentary Pages: 1 - 3

2. Web alert

   • Jaspreet S. Sandhu

   News Pages: 4 - 5

3. Literature alert

   Abstract Pages: 6 - 8

4. A randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2/interferon

   • Ken-ryu Han
   • Allan J. Pantuck
   • Arie S. Belldegrun

   Clinical Trials Report Pages: 11 - 12

5. Minimally invasive ablative approaches in the treatment of renal cell carcinoma

   • Nicolette Janzen
   • Amnon Zisman
   • Arie S. Belldegrun

   OriginalPaper Pages: 13 - 20

6. Laparoscopic radical nephrectomy for advanced kidney cancer

   • Stephen E. Paulter
   • McClellan M. Walther

   OriginalPaper Pages: 21 - 24

7. Kidney pathology: Current classification of renal cell carcinoma

   • Jonathan W. Said
   • George Thomas
   • Amnon Zisman

   OriginalPaper Pages: 25 - 30

8. Prognostic factors for biologic therapy in kidney cancer

   • Beverly J. Drucker

   OriginalPaper Pages: 31 - 36

9. Surgical management of renal cell carcinoma invading the vena cava

   • Matthew T. Gettman
   • Michael L. Blute

   OriginalPaper Pages: 37 - 43

10. The role of adjuvant immunotherapy in renal cell carcinoma

    • Peter F. A. Mulders
    • Pieter H. M. de Mulder

    OriginalPaper Pages: 44 - 49

11. DNA microarrays in prostate cancer

    • Shuk-Mei Ho
    • Kin-Mang Lau

    OriginalPaper Pages: 53 - 60

12. Sacral neuromodulation for the treatment of bladder dysfunction

    • Jennifer MaLossi
    • Toby C. Chai

    OriginalPaper Pages: 61 - 66

13. A novel method for the analysis of the androgen receptor

    • Kris E. Gaston
    • O. Harris Ford III
    • James L. Mohler

    OriginalPaper Pages: 67 - 74

14. Gene therapy for urologic cancer

    • Fernando A. Ferrer
    • Ronald Rodriguez

    OriginalPaper Pages: 75 - 81

15. Immune gene therapy in urology

    • Ingo Kausch
    • Peter Ardelt
    • Timothy L. Ratliff

    OriginalPaper Pages: 82 - 89